Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway - PubMed (original) (raw)
. 1995 Aug 4;270(31):18531-8.
doi: 10.1074/jbc.270.31.18531.
Affiliations
- PMID: 7629182
- DOI: 10.1074/jbc.270.31.18531
Free article
Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway
T A Lin et al. J Biol Chem. 1995.
Free article
Abstract
PHAS-I levels increased 8-fold as 3T3-L1 fibroblasts differentiated into adipocytes and acquired sensitivity to insulin. Insulin increased PHAS-I protein (3.3-fold after 2 days), the rate of PHAS-I synthesis (3-fold after 1 h), and the half-life of the protein (from 1.5 to 2.5 days). Insulin also increased the phosphorylation of PHAS-I and promoted dissociation of the PHAS-I eukaryotic initiation factor-4E (eIF-4E) complex, effects that were maximal within 10 min. With recombinant [H6]PHAS-I as substrate, mitogen-activated protein (MAP) kinase was the only insulin-stimulated PHAS-I kinase detected after fractionation of extracts by Mono Q chromatography; however, MAP kinase did not readily phosphorylate [H6]PHAS-I when the [H6]PHAS-I.eIF-4E complex was the substrate. Thus, while MAP kinase may phosphorylate free PHAS-I, it is not sufficient to dissociate the complex. Moreover, rapamycin attenuated the stimulation of PHAS-I phosphorylation by insulin and markedly inhibited dissociation of PHAS-I.eIF-4E, without decreasing MAP kinase activity. Rapamycin abolished the effects of insulin on increasing phosphorylation of ribosomal protein S6 and on activating p70S6K. The MAP kinase kinase inhibitor, PD 098059, markedly decreased MAP kinase activation by insulin, but it did not change PHAS-I phosphorylation or the association of PHAS-I with eIF-4E. In summary, insulin increases the expression of PHAS-I and promotes phosphorylation of multiple sites in the protein via multiple transduction pathways, one of which is rapamycin-sensitive and independent of MAP kinase. Rapamycin may inhibit translation initiation by increasing PHAS-I binding to eIF-4E.
Similar articles
- Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways.
Azpiazu I, Saltiel AR, DePaoli-Roach AA, Lawrence JC. Azpiazu I, et al. J Biol Chem. 1996 Mar 1;271(9):5033-9. doi: 10.1074/jbc.271.9.5033. J Biol Chem. 1996. PMID: 8617780 - PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation.
Lawrence JC Jr, Fadden P, Haystead TA, Lin TA. Lawrence JC Jr, et al. Adv Enzyme Regul. 1997;37:239-67. doi: 10.1016/s0065-2571(96)00016-7. Adv Enzyme Regul. 1997. PMID: 9381973 Review. - Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells.
Diggle TA, Moule SK, Avison MB, Flynn A, Foulstone EJ, Proud CG, Denton RM. Diggle TA, et al. Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):447-53. doi: 10.1042/bj3160447. Biochem J. 1996. PMID: 8687386 Free PMC article. - cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells.
Graves LM, Bornfeldt KE, Argast GM, Krebs EG, Kong X, Lin TA, Lawrence JC Jr. Graves LM, et al. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7222-6. doi: 10.1073/pnas.92.16.7222. Proc Natl Acad Sci U S A. 1995. PMID: 7638171 Free PMC article. - Insulin signaling and the control of PHAS-I phosphorylation.
Lawrence JC Jr, Brunn GJ. Lawrence JC Jr, et al. Prog Mol Subcell Biol. 2001;26:1-31. doi: 10.1007/978-3-642-56688-2_1. Prog Mol Subcell Biol. 2001. PMID: 11575163 Review. No abstract available.
Cited by
- Activation of ERK and p38 Reduces AZD8055-Mediated Inhibition of Protein Synthesis in Hepatocellular Carcinoma HepG2 Cell Line.
Jee HY, Lee YG, Lee S, Elvira R, Seo HE, Lee JY, Han J, Lee K. Jee HY, et al. Int J Mol Sci. 2021 Oct 30;22(21):11824. doi: 10.3390/ijms222111824. Int J Mol Sci. 2021. PMID: 34769253 Free PMC article. - Culprits or consequences: Understanding the metabolic dysregulation of muscle in diabetes.
O'Reilly CL, Uranga S, Fluckey JD. O'Reilly CL, et al. World J Biol Chem. 2021 Sep 27;12(5):70-86. doi: 10.4331/wjbc.v12.i5.70. World J Biol Chem. 2021. PMID: 34630911 Free PMC article. Review. - Molecular mechanisms of cancer cachexia‑induced muscle atrophy (Review).
Yang W, Huang J, Wu H, Wang Y, Du Z, Ling Y, Wang W, Wu Q, Gao W. Yang W, et al. Mol Med Rep. 2020 Dec;22(6):4967-4980. doi: 10.3892/mmr.2020.11608. Epub 2020 Oct 16. Mol Med Rep. 2020. PMID: 33174001 Free PMC article. Review. - From Gene to Protein-How Bacterial Virulence Factors Manipulate Host Gene Expression During Infection.
Denzer L, Schroten H, Schwerk C. Denzer L, et al. Int J Mol Sci. 2020 May 25;21(10):3730. doi: 10.3390/ijms21103730. Int J Mol Sci. 2020. PMID: 32466312 Free PMC article. Review. - The Protozoan Parasite Toxoplasma gondii Selectively Reprograms the Host Cell Translatome.
Leroux LP, Lorent J, Graber TE, Chaparro V, Masvidal L, Aguirre M, Fonseca BD, van Kempen LC, Alain T, Larsson O, Jaramillo M. Leroux LP, et al. Infect Immun. 2018 Aug 22;86(9):e00244-18. doi: 10.1128/IAI.00244-18. Print 2018 Sep. Infect Immun. 2018. PMID: 29967092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases